ArticleCirculation2020

Ibrutinib-Mediated Atrial Fibrillation Attributable to Inhibition of C-Terminal Src Kinase.

Ling Xiao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.